Neuphoria Therapeutics Inc Cash Flow Quality Index
Neuphoria Therapeutics Inc cash flow quality index. Neuphoria Therapeutics Inc (NEUP) has a Cash Flow Quality Index of -3.45x as of December 2025. Operating cash flow of $-6.44 Million is below net income of $1.86 Million, suggesting accrual-heavy earnings not yet converted to cash. See NEUP financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Neuphoria Therapeutics Inc (2014–2014)
Cash flow quality index of Neuphoria Therapeutics Inc from 2014 to 2014. Historical Cash Flow Quality Index for Neuphoria Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Neuphoria Therapeutics Inc (NEUP) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Neuphoria Therapeutics Inc Cash Flow Quality Index by Year (2014–2014)
Neuphoria Therapeutics Inc cash flow quality index by year from 2014 to 2014. Year-by-year earnings quality comparison for Neuphoria Therapeutics Inc. For the full cash flow conversion analysis, see Neuphoria Therapeutics Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | -4.28x | $-12.91 Million | $3.02 Million | — |